scispace - formally typeset
R

Robert F. Todd

Researcher at University of Michigan

Publications -  100
Citations -  7238

Robert F. Todd is an academic researcher from University of Michigan. The author has contributed to research in topics: Receptor & Antigen. The author has an hindex of 44, co-authored 99 publications receiving 7127 citations. Previous affiliations of Robert F. Todd include University of Pennsylvania & Monsanto.

Papers
More filters
Journal ArticleDOI

Regulation of transendothelial neutrophil migration by endogenous interleukin-8

TL;DR: Endothelial cell production of a 77-amino acid variant of interleukin-8 (IL-8) was found to be a requirement for the invasion of neutrophils through a vessel wall model and regulates transvenular traffic during acute inflammatory responses.
Journal ArticleDOI

Immunologic classification of leukemia and lymphoma.

TL;DR: It is now clear that acute lymphoblastic leukemia (ALL) is heterogeneous and monoclonal antibodies that identify B cells, such as the anti-B1 andAnti-B4 antibodies in combination with studies of immunoglobulin gene rearrangement, have demonstrated that virtually all cases of non-T-ALL are malignancies of B cell origin.
Journal ArticleDOI

The urokinase receptor is required for human monocyte chemotaxis in vitro.

TL;DR: It is demonstrated that expression and unimpeded function of uPAR plays an obligate role in M phi chemotaxis by mechanisms that are largely independent of its ligand, uPA.
Journal Article

Urokinase-Type Plasminogen Activator Receptors Associate with β1 and β3 Integrins of Fibrosarcoma Cells: Dependence on Extracellular Matrix Components

TL;DR: In this paper, the effect of saccharides on the β1 and β3 integrin-uPAR colocalization and RET was investigated. But the results showed that β1 integrin colocalisation and RET were effectively inhibited by N -acetyl-d-glucosamine on extracellular matrix-coated surfaces.
Journal ArticleDOI

Anti‐CD11b monoclonal antibody reduces ischemic cell damage after transient focal cerebral ischemia in rat

TL;DR: The data demonstrate that administration of anti‐CD11b antibody results in a dose‐dependent, significant functional improvement and reduction of ischemic cell damage after transient focal cerebral ischemia in the rat.